Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Mark J. Osborn(University of Minnesota), Bruce R. Blazar(University of Minnesota Medical Center), Michael C. Jensen(Seattle Children's Hospital), Anthony P. DeFeo(University of Minnesota), Karen S. Kelly‐Spratt(Fred Hutch Cancer Center), Nicole Tennis(University of Minnesota), Jeffrey S. Miller(Science Museum of Minnesota), Troy C. Lund(University of Minnesota Medical Center), Daniel F. Voytas(University of Minnesota), Colby G. Starker(University of Minnesota), Manfred Schmidt(Centre National de la Recherche Scientifique), Jakub Tolar(University of Minnesota System), Andrew M. Scharenberg(CTI BioPharma (Italy)), Sarah C. Merkel(University of Minnesota), Keli L. Hippen(University of Minnesota Medical Center), Amber McElroy(University of Minnesota Medical Center), Christof von Kalle(Luxembourg Institute of Health), Friederike Knipping(German Cancer Research Center), Catherine Lee(University of Minnesota), Beau R. Webber(University of Minnesota), Richard Gabriel(German Cancer Research Center), Cara-lin Lonetree(University of Minnesota)
Cited by 201
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k